
Ecolab Life Sciences Opens Bioprocessing Laboratory in US
Ecolab Life Sciences has officially opened its new US Bioprocessing Applications Laboratory in Pennsylvania.
Ecolab Life Sciences has officially opened its new US Bioprocessing Applications Laboratory in Pennsylvania.
Gelest, a Mitsubishi Chemical Group company, announced the opening of its new production facility in the US.
Bristol Myers Squibb appoints Cari Gallman as EVP and invests $40 billion in the US over 5 years.
Perstorp and BRB, subsidiaries of Petronas Chemicals Group (PCG), inaugurated an innovation hub in Shanghai, China. The laboratory will support growth in the region by increasing technical support for customers.
Merck Wilmington Biotech will serve as a launch and commercial production facility and the future US home for Keytruda.
Roche recently announced that it will invest $50 billion (€43.8 billion) into the United States in the next five years.
Cellasto, the world leader in Noise, Vibration and Harshness (NVH) components, is investing roughly €60 million to establish a second plant in Shanghai, China.
To meet growing demand from the pharmaceutical industry, Asahi Kasei has established Asahi Kasei Life Science to operate its bioprocess businesses under a new organizational structure.
Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.
Solvay has officially inaugurated its rare earths production line for permanent magnets at the La Rochelle facility, marking a significant milestone in the Group’s commitment to meeting Europe’s strategic goals.
NBE Therapeutics (NBE), a wholly owned subsidiary of Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel.
New facility will focus on crosslinkers and binders, with the potential to test tens of thousands of formulations per year. Digitalization and automation enable data-driven research and development, while networked robotics allow more efficient data generation for segment-specific application testing.
Vynova Alkoxides GmbH is beginning the construction of a new alcoholates plant at Chemiepark Lülsdorf GmbH in Lülsdorf, Germany.
US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.
OMV has announced the expansion of its innovative ReOil technology at the Schwechat refinery near Vienna.
Britain’s AstraZeneca wants to invest $2.5 billion in Beijing, China to establish its sixth global strategic R&D center.
Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.
Syngene, a global contract research, development, and manufacturing organization (CRDMO), recently announced the acquisition of its first biologics site in the USA – fitted with multiple monoclonal antibody (mAbs) manufacturing lines.
Axplora, an API small molecule and ADC (antibody-drug conjugate) manufacturer, is strengthening its position in the commercial manufacturing ADCs by launching a cutting-edge payload manufacturing workshop at its Le Mans site (France).
German contract development and manufacturing organization (CDMO) Adragos Pharma has completed a €4 million project to install and commission a new, cGMP-compliant liquid drug filling line and associated cartoning machine at its plant in Leipzig, Germany.
Contract development and manufacturing organization (CDMO) CordenPharma has finalized plans to establish a new peptide manufacturing facility in Switzerland located at Getec Park in Muttenz near Basel. This investment is part of the company’s growth initiatives with a more than €1 billion strategic investment in peptide development and manufacturing.
Toray Industries has opened the Toray Taiwan Technical Center. This new facility aims to enhance research and development in advanced semiconductor technologies and materials, and provide technical services in the Taiwan market, which plays a significant role in the global semiconductor supply chain.
Eli Lilly plans to invest $27 billion to bolster its domestic medicine production across several therapeutic areas by building four new manufacturing sites in the US.
The 15% capacity expansion of Arkema’s PVDF production site in Calvert City, Kentucky, represents an investment of approximately $20 million (€19 million).
BASF India Ltd. has broken ground on a new plant to increase the production capacity of its Cellasto microcellular polyurethane (MCU) in Dahej, India.
Nouryon plans to expand its chromatography media manufacturing facility in Bohus, Sweden, doubling the site’s capacity. Construction will begin in early 2025, and the start of production is expected in early 2027, the company said.
Henkel recently announced the opening of its new Application Center in Busan, South Korea, marking a significant investment in the global sports & fashion industry.
German specialty chemicals company Lanxess inaugurated its India Application Development Center (IADC) in Mumbai.
TotalEnergies and Air Liquide have signed agreements to develop two projects in the Netherlands, for the production and delivery of some 45,000 t/y of green hydrogen produced using renewable power, generated mostly by the OranjeWind offshore wind farm, developed by TotalEnergies (50%) and RWE (50%).
Fujifilm plans to invest approximately €25 million to install new production facilities for chemical mechanical planarization (CMP) slurries, which are used in advanced semiconductors, as well as enhance existing facilities for photolithography-related materials at its site in Antwerp, Belgium.
Global integrated energy group OQ announced that three companies, representing a combined investment of $42 million, will start operations at Oman’s Ladayn Polymer Park in early 2025.
Spanish energy and petrochemicals group Repsol has approved an investment of more than €800 million to build its Ecoplant in the area of Tarragona, Spain. The first of its kind in Europe, the facility will use urban waste to produce renewable fuels and circular products through gasification, the company said.
UK contract development and manufacturing organization (CDMO) Upperton Pharma Solutions, has completed its new sterile manufacturing facility in Nottingham, UK, expanding its capacity in addition to its existing 50,000-square-foot site at Trent Gateway.
Solvias, a Switzerland-headquartered provider of chemistry, manufacturing, and control (CMC) analytics, has opened the first phase of its 50,000-square-foot testing center for biologics and cell and gene therapy in Research Triangle Park (RTP), North Carolina, US.
To support the move to a larger office facility in the Greater Toronto Area, Ontario, AstraZeneca plans to invest $570 million in Canada, creating more than 700 jobs.